These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32056382)

  • 1. Pharmacology and physiological function of the orphan GPRC6A receptor.
    Jørgensen CV; Bräuner-Osborne H
    Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6():77-87. PubMed ID: 32056382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and skeletal homeostasis are maintained in full locus GPRC6A knockout mice.
    Jørgensen CV; Gasparini SJ; Tu J; Zhou H; Seibel MJ; Bräuner-Osborne H
    Sci Rep; 2019 Apr; 9(1):5995. PubMed ID: 30979912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function.
    Clemmensen C; Smajilovic S; Wellendorph P; Bräuner-Osborne H
    Br J Pharmacol; 2014 Mar; 171(5):1129-41. PubMed ID: 24032653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome.
    Pi M; Chen L; Huang MZ; Zhu W; Ringhofer B; Luo J; Christenson L; Li B; Zhang J; Jackson PD; Faber P; Brunden KR; Harrington JJ; Quarles LD
    PLoS One; 2008; 3(12):e3858. PubMed ID: 19050760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks.
    Pi M; Quarles LD
    Endocrinology; 2012 May; 153(5):2062-9. PubMed ID: 22374969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for a bone phenotype in GPRC6A knockout mice under normal physiological conditions.
    Wellendorph P; Johansen LD; Jensen AA; Casanova E; Gassmann M; Deprez P; Clément-Lacroix P; Bettler B; Bräuner-Osborne H
    J Mol Endocrinol; 2009 Mar; 42(3):215-23. PubMed ID: 19103720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel extracellular cation-sensing G-protein-coupled receptor.
    Pi M; Faber P; Ekema G; Jackson PD; Ting A; Wang N; Fontilla-Poole M; Mays RW; Brunden KR; Harrington JJ; Quarles LD
    J Biol Chem; 2005 Dec; 280(48):40201-9. PubMed ID: 16199532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants.
    Rueda P; Harley E; Lu Y; Stewart GD; Fabb S; Diepenhorst N; Cremers B; Rouillon MH; Wehrle I; Geant A; Lamarche G; Leach K; Charman WN; Christopoulos A; Summers RJ; Sexton PM; Langmead CJ
    PLoS One; 2016; 11(1):e0146846. PubMed ID: 26785252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust GLP-1 secretion by basic L-amino acids does not require the GPRC6A receptor.
    Clemmensen C; Jørgensen CV; Smajilovic S; Bräuner-Osborne H
    Diabetes Obes Metab; 2017 Apr; 19(4):599-603. PubMed ID: 27943578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired osteoblast function in GPRC6A null mice.
    Pi M; Zhang L; Lei SF; Huang MZ; Zhu W; Zhang J; Shen H; Deng HW; Quarles LD
    J Bone Miner Res; 2010 May; 25(5):1092-102. PubMed ID: 19874200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPRC6A: Jack of all metabolism (or master of none).
    Pi M; Nishimoto SK; Quarles LD
    Mol Metab; 2017 Feb; 6(2):185-193. PubMed ID: 28180060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineation of the GPRC6A receptor signaling pathways using a mammalian cell line stably expressing the receptor.
    Jacobsen SE; Nørskov-Lauritsen L; Thomsen AR; Smajilovic S; Wellendorph P; Larsson NH; Lehmann A; Bhatia VK; Bräuner-Osborne H
    J Pharmacol Exp Ther; 2013 Nov; 347(2):298-309. PubMed ID: 24008333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipocyte-specific GPRC6A ablation promotes diet-induced obesity by inhibiting lipolysis.
    Mukai S; Mizokami A; Otani T; Sano T; Matsuda M; Chishaki S; Gao J; Kawakubo-Yasukochi T; Tang R; Kanematsu T; Takeuchi H; Jimi E; Hirata M
    J Biol Chem; 2021; 296():100274. PubMed ID: 33428938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variations in the Human G Protein-coupled Receptor Class C, Group 6, Member A (GPRC6A) Control Cell Surface Expression and Function.
    Jørgensen S; Have CT; Underwood CR; Johansen LD; Wellendorph P; Gjesing AP; Jørgensen CV; Quan S; Rui G; Inoue A; Linneberg A; Grarup N; Jun W; Pedersen O; Hansen T; Bräuner-Osborne H
    J Biol Chem; 2017 Jan; 292(4):1524-1534. PubMed ID: 27986810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.
    Ye R; Pi M; Cox JV; Nishimoto SK; Quarles LD
    J Exp Clin Cancer Res; 2017 Jun; 36(1):90. PubMed ID: 28659174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Explaining Divergent Observations Regarding Osteocalcin/GPRC6A Endocrine Signaling.
    Pi M; Nishimoto SK; Darryl Quarles L
    Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33474566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased susceptibility to diet-induced obesity in GPRC6A receptor knockout mice.
    Clemmensen C; Smajilovic S; Madsen AN; Klein AB; Holst B; Bräuner-Osborne H
    J Endocrinol; 2013 May; 217(2):151-60. PubMed ID: 23428581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells.
    Ye R; Pi M; Nooh MM; Bahout SW; Quarles LD
    Mol Pharmacol; 2019 May; 95(5):563-572. PubMed ID: 30894404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPRC6A mediates the non-genomic effects of steroids.
    Pi M; Parrill AL; Quarles LD
    J Biol Chem; 2010 Dec; 285(51):39953-64. PubMed ID: 20947496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPRC6A regulates prostate cancer progression.
    Pi M; Quarles LD
    Prostate; 2012 Mar; 72(4):399-409. PubMed ID: 21681779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.